However, the use of cell-based assays with full-length natively-folded MOG for the detection of human MOG immunoglobulin G antibodies (MOG-IgG) in patients with acquired demyelinating diseases (ADS) showed that MOG-IgG-associated disease (MOGAD) represents a disease distinct from MS (1,11). Here, MOG is linked to myeloid sarcoma.